After search, choose a molecule or a kind of categories listed in the left to narrow down your filter. If you have any problems, please contact us!

Быстрый заказ

Text Size:AAA

SerpinD1 Антитело, Кроличье моноклональное антитело

ПаспортОбзорыСвязанные продуктыПротоколы
Human SERPIND1 Информация о продуктах-антителах
Иммуноген:Recombinant Human SerpinD1 protein (Catalog#10295-H08H)
Clone ID:008
Тип Ig:Rabbit IgG
Концентрация:
Эндотоксин:
Состав:0.2 μm filtered solution in PBS with 5% trehalose
Подготовка:This antibody was obtained from a rabbit immunized with purified, recombinant Human SerpinD1 (rh SerpinD1; Catalog#10295-H08H; NP_000176.2; Met1-Ser499).
Human SERPIND1 Руководство по использованию антител
Специфика:Human SerpinD1
Has cross-reactivity in ELISA with
Mouse SerpinD1
No cross-reactivity in ELISA with
Human SerpinA3
Human SerpinC1
Human SerpinI1
Mouse SerpinF1
Заявление:IHC-P

IHC-P: 1-10 μg/mL

Склад:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Human SERPIND1 Antibody IHC Application Image
SerpinD1 Antibody, Rabbit MAb, Immunohistochemistry
[Щелкните, чтобы увеличить изображение]
Caption:
Immunochemical staining of human serpinD1 in human hepatoma with rabbit monoclonal antibody (5 µg/mL, formalin-fixed paraffin embedded sections). Positive staining was localized to hepatocyte.
SerpinD1 Antibody, Rabbit MAb, Immunohistochemistry
[Щелкните, чтобы увеличить изображение]
Caption:
Immunochemical staining of human serpinD1 in human liver with rabbit monoclonal antibody (5 µg/mL, formalin-fixed paraffin embedded sections). Positive staining was localized to hepatocyte.
Other SERPIND1 Antibody Products
SerpinD1 Фон

SerpinD1, also known as heparin cofactor II (HCâ…¡), is a member of Serpin superfamily of the serine proteinase inhibitors. HCII is a glycoprotein in human plasma that inhibits thrombin and chymotrypsin, and the rate of inhibition of thrombin is rapidly increased by Dermatan sulfate (DS), heparin (H) and glycosaminoglycans(GAG). The stimulatory effect of glycosaminoglycans on the inhibition is mediated, in part, by the N-terminal acidic domain of HCII. Interestingly, a C-terminal His-tagged recombinant HCII exhibits enhanced activity of thrombin inhibition. It has been suggested that HCII plays an unique and important role in vascular homeostasis, and accordingly mutations in this gene or congenital HCII deficiency is potentially associated with thrombosis. HCII specifically inhibits thrombin action at the site of vascular wall injury and HCII-thrombin complexes have been detected in human plasma. HCII protects against thrombin-induced vascular remodeling in both humans and mice and suggest that HCII is a predictive biomarker and therapeutic target for atherosclerosis. SerpinD1 also inhibits chymotrypsin, but in a glycosaminoglycan-independent manner.

Human SerpinD1 Ссылки
  • Rau JC, et al. (2009) Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Exp Mol Pathol. 87(3): 178-83.
  • Aihara K, et al. (2009) Heparin cofactor II as a novel vascular protective factor against atherosclerosis. J Atheroscler Thromb. 16(5): 523-31.
  • Product nameProduct name
    Size / Price
    Каталог: 10295-R008-50
    Цена по прейскуранту: 
    Цена:      (You Save: )
    Contact Us
    Изображения
    • SerpinD1 Antibody, Rabbit MAb, Immunohistochemistry
    • SerpinD1 Antibody, Rabbit MAb, Immunohistochemistry
      Недавно просмотренные товары
        All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.
        Внимание: все продукты «ПРЕДНАЗНАЧЕНЫ ИСКЛЮЧИТЕЛЬНО ДЛЯ ИССЛЕДОВАНИЙ И НЕ ПРЕДНАЗНАЧЕНЫ ДЛЯ ДИАГНОСТИКИ ИЛИ ТЕРАПЕВТИЧЕСКОГО ЛЕЧЕНИЯ».